Financhill
Back

The New York Times Co. Vs. Cidara Therapeutics, Inc. Industry Stock Comparison

Buy
86

NYT
The New York Times Co.

Last Price:
$70.79
Seasonality Move:
5.79%
Buy
80

CDTX
Cidara Therapeutics, Inc.

Last Price:
$220.73
Seasonality Move:
11.35%
Buy
86
The New York Times Co. (NYT) is a Buy

Is The New York Times Co. a Buy, Sell or Hold?

  • The current The New York Times Co. [NYT] share price is $70.79. The Score for NYT is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
  • NYT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
80
Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Cidara Therapeutics, Inc. [CDTX] share price is $220.80. The Score for CDTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NYT Stock Price Chart

What is The New York Times Co.'s stock price today?

  • The The New York Times Co. share price today is $70.79
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NYT is experiencing slight selling pressure.

CDTX Stock Price Chart

What is Cidara Therapeutics, Inc.'s stock price today?

  • The Cidara Therapeutics, Inc. share price today is $220.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

NYT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.19 Buy
Relative Strength Index (14 RSI): 81.3 Buy
Chaikin Money Flow: -68133 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.45 - 67.91) Buy
Bollinger Bands (100): (55.74 - 63.94) Buy

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 15.77 Buy
Relative Strength Index (14 RSI): 85.1 Buy
Chaikin Money Flow: 991653 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (219.01 - 220.61) Buy
Bollinger Bands (100): (55.63 - 178.69) Buy

NYT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 68.65 Buy
20-day SMA: 66.2 Buy
50-day SMA: 61.77 Buy
200-day SMA: 56.22 Buy
8-day EMA: 68.7 Buy
20-day EMA: 66.52 Buy
50-day EMA: 63.24 Buy
200-day EMA: 57.7 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 220.26 Buy
20-day SMA: 220.14 Buy
50-day SMA: 161.87 Buy
200-day SMA: 73.76 Buy
8-day EMA: 220.14 Buy
20-day EMA: 210.53 Buy
50-day EMA: 173.33 Buy
200-day EMA: 94.53 Buy

The New York Times Co. Earnings Growth & NYT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.25 per share.

Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

The New York Times Co. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):